| 发明名称 |
Drug Delivery Technology |
| 摘要 |
The invention provides a pharmaceutical composition for the transmucosal delivery of a PDE5 inhibitor, said composition comprising a PDE5 inhibitor and a carrier in which said PDE5 inhibitor is soluble or forms a suspension or emulsion. The invention also provides a pharmaceutical composition comprising a PDE5 inhibitor for use in inhibiting PDE activity in vivo, where in said use said composition is delivered by the transmucosal route. |
| 申请公布号 |
US2015005307(A1) |
申请公布日期 |
2015.01.01 |
| 申请号 |
US201214367312 |
申请日期 |
2012.12.19 |
| 申请人 |
LondonPharma Ltd. |
发明人 |
Sams Martin James;High Juliet Victoria;Jamieson Paul Andrew;Booles Clive |
| 分类号 |
A61K9/00;A61K31/53;A61K47/34;A61K47/10;A61K47/12;A61K47/26;A61K31/519;A61K31/4985 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of preventing or treating a sexual dysfunction, pulmonary hypertension, a vascular or cardiac or neurodegenerative condition, a physical injury, multiple sclerosis or fetal growth restriction in an individual, comprising delivering by sublingual administration as a spray a composition that comprises: a PDE5 inhibitor; and a carrier in which said PDE5 inhibitor is soluble or forms a suspension or emulsion. |
| 地址 |
Norwich, Norfolk GB |
